BethAnn McLaughlin, Ph.D., a neuroscientist at Vanderbilt University Medical Center, has been invited to serve as a reviewing editor for the Journal of Neuroscience, the flagship publication of the Society of Neuroscience, one of the world’s largest scientific societies.

Vanderbilt researchers have discovered a possible molecular mechanism of schizophrenia that could lead to new treatments for the disorder.

A novel mechanism could point to new therapies for a group of inherited diseases that share pathological features.

Understanding how the protein TRPV1 helps neurons survive after glaucoma-related stressors could lead to new therapeutic strategies for glaucoma and other neurodegenerative conditions.

An ion channel protein called TRIPV1 helps retinal neurons survive the elevated eye pressure associated with glaucoma.

Children with autism spectrum disorders have trouble integrating simultaneous information from their eyes and their ears--as if they experience the world like a badly-dubbed movie.

Children with autism spectrum disorder are better at perceiving the motion of certain objects than are typically developing children their age.